Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H PORTER

Showing results (461-470 of 885) with videos related to

Pageof 89
Sort By:
The Journal of the Kentucky Medical Association|December 1, 1977
Review and management of acute epiglottitis by orotracheal vs. nasotracheal intubationR L Long, F H Porter, H T Maguire, et al.
The Journal of Pathology|December 1, 1971
Haemangiomatosis of the small and large bowel with histological malignant changeI M Murray-Lyon, D Doyle, R M Philpott, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 26, 2004
Influence of physicochemical properties on the patterns of association of a series of aliphatic esters of halofantrine with plasma lipoproteinsMichelle P McIntosh, William N Charman, Michael Campbell, et al.
Behavioural Pharmacology|September 20, 2005
Generalization to atypical antipsychotic drugs depends on training dose in rats trained to discriminate 1.25 mg/kg clozapine versus 5.0 mg/kg clozapine versus vehicle in a three-choice drug discrimination taskA J Prus, S D Philibin, A L Pehrson, et al.
Behavioural Pharmacology|June 30, 2011
The metabolites N-desmethylclozapine and N-desmethylolanzapine produce cross-tolerance to the discriminative stimulus of the atypical antipsychotic clozapine in C57BL/6 miceJason M Wiebelhaus, Kevin A Webster, Herbert Y Meltzer, et al.
Behavioural Pharmacology|May 2, 2012
Discriminative stimulus properties of N-desmethylclozapine, the major active metabolite of the atypical antipsychotic clozapine, in C57BL/6 miceJason M Wiebelhaus, Sarah A Vunck, Herbert Y Meltzer, et al.
Physiology & Behavior|January 1, 1987
Exposure to magnetic resonance imaging does not produce taste aversion in ratsJ M Messmer, J H Porter, P Fatouros, et al.
Health Care Management Review|November 17, 2025
Burned out and thinking of quitting: A moderated-mediation model of frontline health care workers and occupational stigma during COVID-19Jessica A Peck, Tracy H Porter, Candice Vander Weerdt, et al.
Molecular Pharmaceutics|March 17, 2021
Digestion of Lipid-Based Formulations Not Only Mediates Changes to Absorption of Poorly Soluble Drugs Due to Differences in Solubilization But Also Reflects Changes to Thermodynamic Activity and PermeabilityYusuke Tanaka, Tri-Hung Nguyen, Estelle J A Suys, et al.
Molecular Pharmaceutics|January 19, 2012
Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulationLisa M Kaminskas, Victoria M McLeod, Christopher J H Porter, et al.
Pageof 89

Showing results (461-470 of 885) with videos related to

Sort By:
Pageof 89
The Journal of the Kentucky Medical Association|December 1, 1977
Review and management of acute epiglottitis by orotracheal vs. nasotracheal intubationR L Long, F H Porter, H T Maguire, et al.
The Journal of Pathology|December 1, 1971
Haemangiomatosis of the small and large bowel with histological malignant changeI M Murray-Lyon, D Doyle, R M Philpott, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 26, 2004
Influence of physicochemical properties on the patterns of association of a series of aliphatic esters of halofantrine with plasma lipoproteinsMichelle P McIntosh, William N Charman, Michael Campbell, et al.
Behavioural Pharmacology|September 20, 2005
Generalization to atypical antipsychotic drugs depends on training dose in rats trained to discriminate 1.25 mg/kg clozapine versus 5.0 mg/kg clozapine versus vehicle in a three-choice drug discrimination taskA J Prus, S D Philibin, A L Pehrson, et al.
Behavioural Pharmacology|June 30, 2011
The metabolites N-desmethylclozapine and N-desmethylolanzapine produce cross-tolerance to the discriminative stimulus of the atypical antipsychotic clozapine in C57BL/6 miceJason M Wiebelhaus, Kevin A Webster, Herbert Y Meltzer, et al.
Behavioural Pharmacology|May 2, 2012
Discriminative stimulus properties of N-desmethylclozapine, the major active metabolite of the atypical antipsychotic clozapine, in C57BL/6 miceJason M Wiebelhaus, Sarah A Vunck, Herbert Y Meltzer, et al.
Physiology & Behavior|January 1, 1987
Exposure to magnetic resonance imaging does not produce taste aversion in ratsJ M Messmer, J H Porter, P Fatouros, et al.
Health Care Management Review|November 17, 2025
Burned out and thinking of quitting: A moderated-mediation model of frontline health care workers and occupational stigma during COVID-19Jessica A Peck, Tracy H Porter, Candice Vander Weerdt, et al.
Molecular Pharmaceutics|March 17, 2021
Digestion of Lipid-Based Formulations Not Only Mediates Changes to Absorption of Poorly Soluble Drugs Due to Differences in Solubilization But Also Reflects Changes to Thermodynamic Activity and PermeabilityYusuke Tanaka, Tri-Hung Nguyen, Estelle J A Suys, et al.
Molecular Pharmaceutics|January 19, 2012
Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulationLisa M Kaminskas, Victoria M McLeod, Christopher J H Porter, et al.
Pageof 89